JY
BCDA icon

Jeff Yass’s BioCardia BCDA Stock Holding History

Jeff Yass’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,107
Closed -$285K – 12008
2023
Q2 		$285K Sell
7,107
-10,713
-60% -$330K ﹤0.01% 9547
2023
Q1 		$524K Buy
17,820
+11,953
+204% +$397K ﹤0.01% 8445
2022
Q4 		$184K Buy
5,867
+2,334
+66% +$66.4K ﹤0.01% 10254
2022
Q3 		$103K Buy
3,533
+2,400
+212% +$62.1K ﹤0.01% 11679
2022
Q2 		$25K Sell
1,133
-1,514
-57% -$36.2K ﹤0.01% 12297
2022
Q1 		$82K Sell
2,647
-833
-24% -$24.7K ﹤0.01% 12034
2021
Q4 		$101K Buy
+3,480
New +$128K ﹤0.01% 12142
2021
Q2 		– Sell
-3,220
Closed -$210K – 12542
2021
Q1 		$210K Buy
+3,220
New +$201K ﹤0.01% 11342

Other funds holding BCDA

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PP
Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jeff Yass's BCDA Position: Q2 2026 in Review

Jeff Yass reduced its BioCardia (BCDA) stake by 0.05% in Q2 2026, selling an estimated $19 and leaving 38,809 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12842.

Jeff Yass first reported a position in BCDA in Q3 2019 and has held it in 18 quarters since. The position peaked at $266K in Q3 2022. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • Jeff Yass held 38,809 shares of BioCardia worth $48.1K as of Q2 2026.
  • Jeff Yass sold 18 BioCardia shares in Q2 2026, an estimated $19.
  • BioCardia made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12842 holding.
  • Jeff Yass first reported a position in BioCardia in Q3 2019 and has held it in 18 quarters since.
  • Jeff Yass's BioCardia position peaked at $266K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.